Vanc led its TSX-v category in trading volume for 2015, which was mostly pre-revenue. The rate in 2016 should start to catch up when more meaningful revenue starts getting reported soon.
| VANC Pharmaceuticals Inc. | NPH | 119% | 191% | 241,384,075 | Clean Technology & Life Sciences | BC |  |  | | Tribute Pharmaceuticals Canada Inc. | TRX | 129% | 176% | 140,738,060 | Clean Technology & Life Sciences | ON | |  | | Canopy Growth Corporation* | CGC | 44% | 340% | 93,764,501 | Clean Technology & Life Sciences | ON |  |  | | Sernova Corp. | SVA | 100% | 118% | 36,704,930 | Clean Technology & Life Sciences | BC | |  | | OrganiGram Holdings Inc. | OGI | 49% | 88% | 55,878,735 | Clean Technology & Life Sciences | NB |  |  | | Medicure Inc. | MPH | 116% | 155% | 8,038,156 | Clean Technology & Life Sciences | MB | |  | | Aphria Inc.* | APH | 22% | 64% | 31,221,455 | Clean Technology & Life Sciences | ON |  |  | | BIOREM Inc.* | BRM | 127% | 165% | 7,012,755 | Clean Technology & Life Sciences | ON |  |  | | bioMmune Technologies Inc.* | IMU | 60% | 120% | 8,444,124 | Clean Technology & Life Sciences | BC | |  | | Clearford Water Systems Inc. | CLI | 33% | 53% | 9,301,634 | Clean Technology & Life Sciences | ON |  |  |
|